Home > Cluster Organisations > EUROBIOMED
Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Thursday, 1 January, 2009
Number of staff in the management team of the cluster organisation : 
11-20
Regions: 
Provence-Alpes-Côte d'Azur
Cluster Excellence Label: 
Bronze Label
Membership to European Strategic Cluster Partnerships (ESCP-4i or ESCP-S3): 
Membership to other networks/partnerships: 
NameWebsite
EDCA
Cluster Management Team: 
NameSurnamePositionTelephoneEmailGender
Morgane
Miltgen
Project Manager
+33(0)4 91 13 74 65
morgane.miltgen@eurobiomed.org
Female
Emilie
Royere
Cluster Manager
+33(0)4 91 13 74 65
emilie.oryere@eurobiomed.org
Female
Languages spoken: 
English
French
Italian
Spanish
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Technology fields: 
Medical Technology / Biomedical Engineering
Pharmaceutical Products / Drugs
S3 EU priority areas: 
e-Health (e.g. healthy ageing)
Human health activities (medical services)
Emerging industries: 
Biopharmaceuticals
Digital Industries
Composition of the cluster
Total number of members: 
280
Number of SME members: 
240
Number of larger company members: 
7
Number of research organisations/universities/technology centres: 
10
Number of other ecosystem actors : 
3
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Name and link of major players: 
NameWebsiteType
Marseille Immunopole
Technology Center
Cluster Strategy
Mission/Objectives: 

EUROBIOMED is the Life Science cluster from Southern France. We gather more than 250 innovative biotech and medtech companies, as well as leading research institutes, hospitals and universities. We lead territorial initiatives and help our members businesses and research organisations to innovate, finance, develop and achieve their scientific and business objectives, to ultimately improve the treatment and the lives of patients.

Founded in 2009 by regional stakeholders, EUROBIOMED tops European rankings in all stages of innovation: education, basic research, translational and clinical research, technological innovation centers, start-ups and manufacturing.

Together, the 253 EUROBIOMED members from 200 different companies are a driving force in regional development (with 160 projects, representing 585 million EUR of investment and 700 direct jobs) and a source of solutions for millions of patients coping with serious conditions such as cancer, chronic inflammatory disease, infectious and (re)emerging diseases, neurological diseases, and rare diseases.

Our missions

EUROBIOMED provides resources and offers solutions for businesses and research organisations in the health sector to help them innovate, finance, develop and achieve their strategic and business objectives to ultimately improve the treatment and the lives of patients.

Do you have a formalised strategy?: 
Yes
Do you have a specific strategy focus that addresses internationalisation ?: 
Yes
Services
Support services provided: 
Access to the European Internal market
Internationalisation support (= Access to third countries markets)
Access to public support (regional/national programmes, innovation vouchers, etc.)
Access to private funding (connecting to investors, seed-capital, venture-capital, crowd-funding, etc.)
Facilitation of collaboration between members
Details of support services: 

Develop the sector in the South of France

  • Animation and networking of members 
  • Strengthening of the ecosystem 
  • National and international development
  • Representation of the sector to third parties (public authorities, international)
  • Implementation of scientific and business evenT

Structuring and financing of public-private R&D projects

  • Monitoring calls for projects
  • Identification of partners
  • Support for project formation and financing
  • Project follow-up to marketing

Personalised support for businesses

  • Strategic analysis
  • Financing - Fundraising 
  • Commercial development and internationalisation 
  • Regulatory compliance
  • Industrialisation and production
Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
Japan
United States
Our cluster organisation undertook the following international activities to support our members: 
Participation at missions/events/study visits/fairs
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
Belgium
Italy
Spain
Sweden
United Kingdom
Our cluster organisation undertook the following trans-national activities to support our members: 
Support to collaborative activities/etc.
Which clusters do you collaborate with?: 
BIOCOM , USA
LINK-J, Japan
Support Programmes
Participation in Funded Support Programmes: 
European ProgrammesLinkName & Description (Regional/National)
FP7
H2020
CIP/COSME
INTERREG

NEURORESCUE : A 3-years Coordination Action Project issued of the Region of Knowledge (RoK) initiative financed by the 7th Framework Programme of the European Commission. It aimed at stimulating cooperation in European fundamental, clinical and social and behavioural research in mental health, in order to support Europe's leading position in understanding and response to mental disorders, dementia or neurodegenerative diseases. NEURO-RESCUE addressed this challenges bridging the gap between researches into mental disorders and implementing innovative solutions.

DOC2AMU :  An Innovative Doctoral Programme

DOC2AMU is an innovative doctoral programme with the aim of financing 30 3-year doctoral contracts from 2016 to 2021 at Aix-Marseille Université (AMU) in Marseille, France. These positions will be offered in three calls: 2016, 2017 and 2018. The programme is uniquely characterized by principles of interdisciplinarity, intersectoriality, and international exposure (« 3I »).

Guided by personalised and innovative training, a Personal Career Development plan, and an intersectoral mentorship component, DOC2AMU provides a complete training programme to ensure the best career perspectives for its doctoral researchers.

 

ONCONET :

Onconet is a project included in the Interreg Sudoe transnational programme that aims to establish a permanent network of excellence in oncology through the mobilization of health actors in the health field in southwestern Europe in relation to prevention, diagnosis, care and translational research.

This project aims to promote research, technological development and innovation

 

 

Relevant Project References: 
http://cordis.europa.eu/result/rcn/155778_fr.html
Promotion
Why should partners choose you for cooperation?: 

With our network of 280+ members in Life Science, Eurobiomed leads territorial actions to support competitivness of its companies and building more bridges between public and private sector.

With a growing and pro-active european and international experience, we bring our knowledge in terms of cross-collaboration between public and private sectors, between SMEs, we organize actions enabling to gain knowledge in entrepreneurship and  co-innovation, we also have strong skills in dissemination among our members through communications strategies and events. We are expert in building, animating multisectoral plateforms related to Life Sciences.